Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Optimising Outcomes for Glioblastoma through Subspecialisation in a Regional Cancer Centre.
Brain Sci. 2018 Oct 15;8(10):186. doi: 10.3390/brainsci8100186.
Brain Sci. 2018.
PMID: 30326653
Free PMC article.
Redo craniotomy or bevacizumab for symptomatic steroid-refractory true or pseudoprogression following IMRT for glioblastoma.
Cook TA, Jayamanne DT, Wheeler HR, Wong MHF, Parkinson JF, Cook RJ, Kastelan MA, Cove NJ, Brown C, Back MF.
Cook TA, et al. Among authors: cove nj.
Neurooncol Pract. 2021 Jun 9;8(5):601-608. doi: 10.1093/nop/npab034. eCollection 2021 Oct.
Neurooncol Pract. 2021.
PMID: 34594572
Free PMC article.
Item in Clipboard
Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma.
Cuncannon M, Wong M, Jayamanne D, Guo L, Cove N, Wheeler H, Back M.
Cuncannon M, et al. Among authors: cove n.
BMC Cancer. 2019 May 14;19(1):445. doi: 10.1186/s12885-019-5678-1.
BMC Cancer. 2019.
PMID: 31088401
Free PMC article.
Item in Clipboard
Cite
Cite